These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9213214)

  • 1. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
    Cremers B; Flesch M; Südkamp M; Böhm M
    J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue.
    Schwinger RH; Böhm M; Erdmann E
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):892-9. PubMed ID: 1694911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
    Muller CA; Opie LH; McCarthy J; Hofmann D; Pineda CA; Peisach M
    J Am Coll Cardiol; 1998 Jul; 32(1):268-74. PubMed ID: 9669280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.
    Schwinger RH; Böhm M; Erdmann E
    Klin Wochenschr; 1990 Aug; 68(16):797-805. PubMed ID: 2145465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts.
    Clozel JP; Véniant M; Osterrieder W
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):731-6. PubMed ID: 1963792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.
    Brixius K; Mohr V; Müller-Ehmsen J; Hoischen S; Münch G; Schwinger RH
    Br J Pharmacol; 1998 Sep; 125(1):41-8. PubMed ID: 9776342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy.
    Fang LM; Osterrieder W
    Eur J Pharmacol; 1991 Apr; 196(2):205-7. PubMed ID: 1651875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
    Hoischen S; Brixius K; Schwinger RH
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY; Sandmann S; Meissner A; Unger T; Simon R
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE; Hamlin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative selectivity for negative chronotropic and inotropic effects of a novel dihydropyridine derivative CD-832.
    Noguchi K; Masumiya H; Sasaki T; Takahashi K; Araki H; Higuchi S; Tanaka H; Shigenobu K
    Eur J Pharmacol; 1996 Jul; 308(1):53-9. PubMed ID: 8836632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
    Orito K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action.
    Osterrieder W; Holck M
    J Cardiovasc Pharmacol; 1989 May; 13(5):754-9. PubMed ID: 2472524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
    Véniant M; Clozel JP; Hess P; Wolfgang R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S55-8. PubMed ID: 1725005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.
    Hugtenburg JG; Mathy MJ; Beckeringh JJ; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):558-66. PubMed ID: 2615847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations.
    Hugtenburg JG; Mathy MJ; Boddeke HW; Beckeringh JJ; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):567-75. PubMed ID: 2615848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
    Robertson MJ; Lumley P
    Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.